Sarcoidosis

New England Journal of Medicine

Volumn 336, Issue 17, 1997, Pages 1224-1234

  Newman, Lee S ^a,b,c   Rose, Cecile S ^a,b,c   Maier, Lisa A ^b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c Dept of Prev Med and Biometrics ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CORTICOSTEROID; CYCLOSPORIN; GLUCOCORTICOID; HYDROXYCHLOROQUINE; QUINOLONE;

BIOPSY; CLINICAL FEATURE; ELECTROCARDIOGRAM; GRANULOMA; GRANULOMATOSIS; GRANULOMATOUS INFLAMMATION; HEART TRANSPLANTATION; HEREDITY; LUNG FUNCTION TEST; LUNG TRANSPLANTATION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SARCOIDOSIS; SLIT LAMP; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ADRENAL CORTEX HORMONES; BRAIN DISEASES; CARDIOMYOPATHIES; EYE DISEASES; HUMANS; KIDNEY DISEASES; SARCOIDOSIS; SARCOIDOSIS, PULMONARY; SKIN DISEASES;

EID: 0030940381     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199704243361706     Document Type: Review

References (159)

1. Bardinas F, Morera J, Fite E, Plasencia A. Seasonal clustering of sarcoidosis. Lancet 1989;2:455-6.
2. Bresnitz EA, Strom BL. Epidemiology of sarcoidosis. Epidemiol Rev 1983;5:124-56.
3. Henke CE, Henke G, Elveback LR, Beard CM, Ballard DJ, Kurland LT. The epidemiology of sarcoidosis in Rochester, Minnesota: a population-based study of incidence and survival. Am J Epidemiol 1986;123:840-5.
4. Rybicki BA, Major M, Popovich J Jr, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997;145:234-41.
5. Mayock RL, Bertrand P, Morrison CE, Scott JH. Manifestations of sarcoidosis: analysis of 145 patients, with a review of nine series selected from the literature. Am J Med 1963;35:67-89.
6. Reisner D. Observations on the course and prognosis of sarcoidosis: with special consideration of its intrathoracic manifestations. Am Rev Respir Dis 1967;96:361-80.
7. Keller AZ. Hospital, age, racial, occupational, geographical, clinical and survivorship characteristics in the epidemiology of sarcoidosis. Am J Epidemiol 1971;94:222-30.
8. Siltzbach LE, James DG, Neville E, et al. Course and prognosis of sarcoidosis around the world. Am J Med 1974;57:847-52.
9. Mitchell DN, Scadding JG. Sarcoidosis. Am Rev Respir Dis 1974;110:774-802.
10. McNicol MW, Luce PJ. Sarcoidosis in a racially mixed community. J R Coll Physicians Lond 1985;19:179-83.
11. Edmondstone WM, Wilson AG. Sarcoidosis in Caucasians, Blacks, and Asians in London. Br J Dis Chest 1985;79:27-36.
12. Bresnitz EA, Stolley PD, Israel HL, Soper K. Possible risk factors for sarcoidosis: a case-control study. Ann N Y Acad Sci 1986;465:632-42.
13. Yamamoto M, Sharma OP, Hosado Y. The 1991 descriptive definition of sarcoidosis. Sarcoidosis 1992;9:Suppl 1:33-4.
14. Spiteri MA, Johnson M, Epstein O, Sherlock S, Clarke SW, Poulter LW. Immunological features of lung lavage cells from patients with primary biliary cirrhosis may reflect those seen in pulmonary sarcoidosis. Gut 1990;31:208-12.
15. Newman LS. Beryllium disease and sarcoidosis: clinical and laboratory links. Sarcoidosis 1995;12:7-19.
16. Rose CS, Newman LS. Hypersensitivity pneumonitis and chronic beryllium disease. In: Schwarz MI, King TE Jr, eds. Interstitial lung disease. 2nd ed. St. Louis: Mosby-Year Book, 1993:231-54.
17. Kern DG, Neill MA, Wrenn DS, Varone JC. Investigation of a unique time-space cluster of sarcoidosis in firefighters. Am Rev Respir Dis 1993;148:974-80.
18. Rose CS, Martyny IW, Newman LS, et al. "Lifeguard lung": endemic granulomatous pneumonitis in an indoor swimming pool. Am J Public Health (in press).
19. Forst LS, Abraham J. Hypersensitivity pneumonitis presenting as sarcoidosis. Br J Ind Med 1993;50:497-500.
20. Redline S, Barna BP, Tomashefski JF Jr, Abraham IL. Granulomatous disease associated with pulmonary deposition of titanium. Br J Ind Med 1986;43:652-6.
21. Hiraga Y. An epidemiological study of clustering of sarcoidosis cases. Nippon Rinsho 1994;52:1438-42. (In Japanese.)
22. Epps RE, el-Azhary RA, Hellinger WC, Winkelmann RK, Van Scoy RE. Disseminated cutaneous Mycobacterium avium-intracellulare resembling sarcoidosis. J Am Acad Dermatol 1995;33:528.-31.
23. Jawad ASM, Hamour AA, Wenley WG, Scott DGI. An outbreak of acute sarcoidosis with arthropathy in Norfolk. Br J Rheumatol 1989;28:178.
24. Wheat LJ, French MLV, Wass JL. Sarcoidlike manifestations of histoplasmosis. Arch Intern Med 1989;149:2421-6.
25. Parkes SA, Baker SB, Bourdillon RE, Murray CR, Rakshit M. Epidemiology of sarcoidosis in the Isle of Man. 1. A case controlled study. Thorax 1987;42:420-6.
26. Hills SE, Parkes SA, Baker SB. Epidemiology of sarcoidosis in the Isle of Man. 2. Evidence for space-time clustering. Thorax 1987;42:427-30.
27. Edmondstone WM. Sarcoidosis in nurses: is there an association? Thorax 1988;43:342-3.
28. Cullen MR, Kominsky JR, Rossman MD, et al. Chronic beryllium disease in a precious metal refinery: clinical epidemiologic and immunologic evidence for continuing risk from exposure to low level beryllium fume. Am Rev Respir Dis 1987;135:201-8.
29. Parkes SA, Baker SB, Bourdillon RE, et al. Incidence of sarcoidosis in the Isle of Man. Thorax 1985;40:284-7.
30. Skelton HG III, Smith KJ, Johnson FB, Cooper CR, Tyler WF, Lupton GP Zirconium granuloma resulting from an aluminum zirconium complex: a previously unrecognized agent in the development of hypersensitivity granulomas. J Am Acad Dermatol 1993;28:874-6.
31. De Vuyst P, Dumortier P, Schandené L, Estenne M, Verhest A, Yernault J-C. Sarcoidiike lung granulomatosis induced by aluminum dusts. Am Rev Respir Dis 1987;135:493-7.
32. Southern JF, Moscicki RA, Magro C, Dickersin GR, Fallon JR, Bloch KJ. Lymphedema, lymphocytic myocarditis, and sarcoidlike granulomatosis: manifestations of Whipple's disease. JAMA 1989;261:1467-70.
33. Van Etta LL, Filice GA, Ferguson RM, Gerding DN. Corynebacterium equi: a review of 12 cases of human infection. Rev Infect Dis 1983;5:1012-8.
34. Williams WR, Davies BH. Pseudo-leptospires in broncho-alveolar lavage fluid and blood cell cultures. J Exp Pathol 1986;67:167-70.
35. Mangiapan G, Hance AJ. Mycobacteria and sarcoidosis: an overview and summary of recent molecular biological data. Sarcoidosis 1995;12:20-37.
36. Munro CS, Mitchell DN, Poulter LW, Cole PJ. Early cellular responses to intradermal injection of Kveim suspension in normal subjects and those with sarcoidosis. J Clin Pathol 1986;39:176-82.
37. Munro CS, Mitchell DN. The Kveim response: still useful, still a puzzle. Thorax 1987;42:321-31.
38. Holter JF, Park HK, Sjoerdsma KW, Kataria YP. Nonviable autologous bronchoalveolar lavage cell preparations induce intradermal epithelioid cell granulomas in sarcoidosis patients. Am Rev Respir Dis 1992;145:864-71.
39. Burke WMJ, Keogh A, Maloney PJ, Delprado W, Bryant DH, Spratt P. Transmission of sarcoidosis via cardiac transplantation. Lancet 1990;336:1579.
40. Heyll A, Meckenstock G, Aul C, et al. Possible transmission of sarcoidosis via allogeneic bone marrow transplantation. Bone Marrow Transplant 1994;14:161-4.
41. Almenoff PL, Johnson A, Lesser M, Mattman LH. Growth of acid fast L forms from the blood of patients with sarcoidosis. Thorax 1996;51:530-3.
42. Harrington DW, Major M, Rybicki B, Popovich J, Maliarik M, Iannuzzi MC. Familial sarcoidosis: analysis of 91 families. Sarcoidosis 1994;11:240-3.
43. Rybicki BA, Harrington D, Major M, et al. Heterogeneity of familial risk in sarcoidosis. Genet Epidemiol 1996;13:23-33.
44. Brennan NJ, Crean P, Long JP, Fitzgerald MX. High prevalence of familial sarcoidosis in an Irish population. Thorax 1984;39:14-8.
45. Hillerdal G, Nou E, Osterman K, Schmekel B. Sarcoidosis: epidemiology and prognosis - a 15-year European study. Am Rev Respir Dis 1984;130:29-32.
46. Richeldi L, Sorrentino R, Saltini C. HLA-DPB1 glutamate 69: a genetic marker of beryllium disease. Science 1993;262:242-4.
47. 2+: immunogenetics and occupational exposure. Science 1993;262:197-8.
48. Pasturenzi L, Martinetti M, Cuccia M, Cipriani A, Semenzato G, Luisetti M. HLA class I, II, and III polymorphism in Italian patients with sarcoidosis: the Pavia-Padova Sarcoidosis Study Group. Chest 1993;104:1170-5.
49. Smith MJ, Turton CW, Mitchell DN, Turner-Warwick M, Morris LM, Lawler SD. Association of HLA B8 with spontaneous resolution in sarcoidosis. Thorax 1981;36:296-8.
50. Gardner J, Kennedy HG, Hamblin A, Jones E. HLA associations in sarcoidosis: a study of two ethnic groups. Thorax 1984;39:19-22.
51. Lenhart K, Kolek V, Bartova A. HLA antigens associated with sarcoidosis. Dis Markers 1990;8:23-9.
52. Tiwari JL, Terasaki PI. HLA and disease associations. New York: Springer-Verlag, 1985.
53. Eisenberg H, Terasaki PI, Sharma OP, Mickey MR Jr. HLA association studies in black sarcoidosis patients. Tissue Antigens 1978;11:484-6.
54. Whitsett CF, Merritt JC, Mower P, Daffin L. HLA-A,B and DR antigens in North Carolina blacks with sarcoidosis. Tissue Antigens 1983;21:348-50.
55. Ina Y, Takada K, Yamamoto M, Morishita M, Senda Y, Torii Y. HLA and sarcoidosis in the Japanese. Chest 1989;95:1257-61.
56. Arbustini E, Grasso M, Leo G, et al. Polymorphism of angiotensin-converting enzyme gene in sarcoidosis. Am J Respir Crit Care Med 1996;153:851-4.
57. James DG. Clinical picture of sarcoidosis. In: Schwarz MI, King TE Jr, eds. Interstitial lung disease. 2nd ed. St. Louis: Mosby-Year Book, 1993: 159-78.
58. Thomas PD, Hunninghake GW. Current concepts of the pathogenesis of sarcoidosis. Am Rev Respir Dis 1987;135:747-60.
59. Hunninghake GW, Crystal RG. Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Engl J Med 1981;305:429-34.
60. Tsuda T, Kita S. Histochemical study of sarcoid granulomatous lesions. Nippon Rinsho 1994;52:1456-61. (In Japanese.)
61. Inoue Y, King TE Jr, Tinkle SS, Dockstader K, Newman LS. Human mast cell basic fibroblast growth factor in pulmonary fibrotic disorders. Am J Pathol 1996;149:2037-54.
62. du Bois RM. Recent advances in the immunology of interstitial lung disease. Clin Exp Allergy 1991;21:9-16.
63. Fearon DT, Locksley RM. The instructive role of innate immunity in the acquired immune response. Science 1996;272:50-3.
64. Lecossier D, Valeyre D, Loiseau A, et al. Antigen-induced proliferative response of lavage and blood T lymphocytes: comparison of cells from normal subjects and patients with sarcoidosis. Am Rev Respir Dis 1991;144:861-8.
65. Hunninghake GW, Gadek JE, Young RC Jr, Kawanami O, Ferrans VJ, Crystal RG. Maintenance of granuloma formation in pulmonary sarcoidosis by T lymphocytes within the lung. N Engl J Med 1980;302:594-8.
66. Agostini C, Trentin L, Zambello R, et al. CD8 alveolitis in sarcoidosis: incidence, phenotypic characteristics, and clinical features. Am J Med 1993;95:466-72.
67. Saltini C, Kirby M, Trapnell BC, Tamura N, Crystal RG. Biased accumulation of T lymphocytes with "memory"-type CD45 leukocyte common antigen gene expression on the epithelial surface of the human lung. J Exp Med 1990;171:1123-40.
68. + T lymphocytes in bronchoalveolar lavage fluid from sarcoidosis patients correlates with HLA-DR3. Eur J Immunol 1992;22:129-35.
69. Du Bois RM, Kirby M, Balbi B, Saltini C, Crystal RG. T-lymphocytes that accumulate in the lung in sarcoidosis have evidence of recent stimulation of the T-cell antigen receptor. Am Rev Respir Dis 1992;145:1205-11.
70. + T cells in bronchoalveolar lavage fluid and peripheral blood of sarcoidosis patients. Proc Natl Acad Sci U S A 1994;91:4965-9.
71. Forman JD, Klein JT, Silver RF, Liu MC, Greenlee BM, Moller DR. Selective activation and accumulation of oligoclonal Vβ-specific T cells in active pulmonary sarcoidosis. J Clin Invest 1994;94:1533-42.
72. Klein JT, Horn TD, Forman JD, Silver RF, Teirstein AS, Moller DR. Selection of oligoclonal Vβ-specific T cells in the intradermal response to Kveim-Siltzbach reagent in individuals with sarcoidosis. J Immunol 1995;154:1450-60.
73. Dohi M, Yamamoto K, Masuko K, et al. Accumulation of multiple T cell clonotypes in lungs of healthy individuals and patients with pulmonary sarcoidosis. J Immunol 1994;152:1983-8.
74. Bellocq A, Lecossier D, Pierre-Audigier C, Tazi A, Valeyre D, Hance AJ. T cell receptor repertoire of T lymphocytes recovered from the lung and blood of patients with sarcoidosis. Am J Respir Crit Care Med 1994;149:646-54.
75. Forrester JM, Wang Y, Ricalton N, et al. TCR expression of activated T cell clones in the lungs of patients with pulmonary sarcoidosis. J Immunol 1994;153:4291-302.
76. Prior C, Haslam PL. Increased levels of serum interferon-gamma in pulmonary sarcoidosis and relationship with response to corticosteroid therapy. Am Rev Respir Dis 1991;143:53-60.
77. Swider C, Laba A, Moniewska A, Gerdes J, Flad H-D, Lange A. Presence of mRNA for interferon-gamma (IFN-γ) in blood mononuclear cells is associated with an active stage I sarcoidosis. Clin Exp Immunol 1995;100:401-5.
78. Bäumer I, Zissel G, Schlaak M, Müller-Quernheim J. Th1/Th2 cell distribution in pulmonary sarcoidosis. Am J Respir Cell Mol Biol 1997;16:171-7.
79. Tinkle SS, Kittle LA, Schumacher BA, Newman LS. Beryllium induces IL-2 and IFN-γ in berylliosis. J Immunol 1997;158:518-26.
80. Barnes PF, Rom WN. Cytokine production in tuberculosis. In: Rom WN, Garay SM, eds. Tuberculosis. Boston: Little, Brown, 1996:291-303.
81. Wynn TA, Eltoum I, Cheever AW, Lewis FA, Gause WC, Sher A. Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni. J Immunol 1993;151:1430-40.
82. Semenzato G. Immunology of interstitial lung diseases: cellular events taking place in the lung of sarcoidosis, hypersensitivity pneumonitis and HIV infection. Eur Respir J 1991;4:94-102.
83. Standiford TJ, Rolfe MW, Kunkel SL, et al. Macrophage inflammatory protein-1 α expression in interstitial lung disease. J Immunol 1993;151:2852-63.
84. Hamblin AS, Shakoor Z, Kapahi P, Haskard D. Circulating adhesion molecules in sarcoidosis. Clin Exp Immunol 1994;96:335-8.
85. Müller-Quernheim J, Pfeifer S, Männel A, Strausz M, Ferlinz R. Lung-restricted activation of the alveolar macrophage/monocyte system in pulmonary sarcoidosis. Am Rev Respir Dis 1992;145:187-92.
86. Girgis RE, Basha MA, Maliarik M, Popovich J Jr, Iannuzzi MC. Cytokines in the bronchoalveolar lavage fluid of patients with active pulmonary sarcoidosis. Am J Respir Crit Care Med 1995;152:71-5.
87. Bost TW, Riches DWH, Schumacher B, et al. Alveolar macrophages from patients with beryllium disease and sarcoidosis express increased levels of mRNA for tumor necrosis factor-α and interleukin-6 but not interleukin-1β. Am J Respir Cell Mol Biol 1994;10:506-13.
88. 2 release, alveolitis, and disease severity in sarcoidosis. Chest 1993;103:832-8.
89. Steffen M, Petersen J, Oldigs M, et al. Increased secretion of tumor necrosis factor-alpha, interleukin-1-beta, and interleukin-6 by alveolar macrophages from patients with sarcoidosis. J Allergy Clin Immunol 1993;91:939-49.
90. Limper AH, Colby TV, Sanders MS, Asakura S, Roche PC, DeRemee RA. Immunohistochemical localization of transforming growth factor-β1 in the nonnecrotizing granulomas of pulmonary sarcoidosis. Am J Respir Crit Care Med 1994;149:197-204.
91. Roman J, Jeon Y-J, Gal A, Perez RL. Distribution of extracellular matrices, matrix receptors, and transforming growth factor-β1 in human and experimental lung granulomatous inflammation. Am J Med Sci 1995;309:124-33.
92. Eklund AG, Sigurdardottir O, Öhrn M. Vitronectin and its relationship to other extracellular matrix components in bronchoalveolar lavage fluid in sarcoidosis. Am Rev Respir Dis 1992;145:646-50.
93. Pesci A, Bertorelli G, Gabrielli M, Olivieri D. Mast cells in fibrotic lung disorders. Chest 1993;103:989-96.
94. Bertrán G, Arzt E, Resnik E, Mosca C, Nahmod V. Inhibition of interferon gamma production by peripheral blood mononuclear leukocytes of patients with sarcoidosis: pathogenic implications. Chest 1992;101:996-9.
95. Duncan MR, Berman B. Gamma interferon is the lymphokine and β-interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation. J Exp Med 1985;162:516-27.
96. Czaja MJ, Weiner FR, Eghbali M, Giambrone M-A, Eghbali M, Zern MA. Differential effects of γ-interferon on collagen and fibronectin gene expression. J Biol Chem 1987;262:13348-51.
97. Gilman MJ, Wang KP. Transbronchial lung biopsy in sarcoidosis: an approach to determine the optimal number of biopsies. Am Rev Respir Dis 1980;122:721-4.
98. Newman LS. Occupational illness. N Engl J Med 1995;333:1128-34.
99. Mroz MM, Kreiss K, Lezotte DC, Campbell PA, Newman LS. Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease. J Allergy Clin Immunol 1991;88:54-60.
100. Kaplan MM. Primary biliary cirrhosis. N Engl J Med 1996;335:1570-80.
101. Winterbauer RH, Lammert J, Selland M, Wu R, Corley D, Springmeyer SC. Bronchoalveolar lavage cell populations in the diagnosis of sarcoidosis. Chest 1993;104:352-61.
102. Wallaert B, Ramon P, Fournier EC, Prin L, Tonnel AB, Voisin C. Activated alveolar macrophage and lymphocyte alveolitis in extrathoracic sarcoidosis without radiological mediastinopulmonary involvement. Ann N Y Acad Sci 1986;465:201-10.
103. Ohara K, Okubo A, Kamata K, Sasaki H, Kobayashi J, Kitamura S. Transbronchial lung biopsy in the diagnosis of suspected ocular sarcoidosis. Arch Ophthalmol 1993;111:642-4.
104. Harrison BDW, Shaylor JM, Stokes TC, Wilkes AR. Airflow limitation in sarcoidosis - a study of pulmonary function in 107 patients with newly diagnosed disease. Respir Med 1991;85:59-64.
105. Bjermer L, Thunell M, Rosenhall L, Stjernberg N. Endobronchial biopsy positive sarcoidosis: relation to bronchoalveolar lavage and course of disease. Respir Med 1991;85:229-34.
106. Stjernberg N, Thunell M. Pulmonary function in patients with endobronchial sarcoidosis. Acta Med Scand 1984;215:121-6.
107. James DG. Lupus pernio. Lupus 1992;1:129-31.
108. Case Records of the Massachusetts General Hospital (Case 2-1990). N Engl J Med 1990;322:116-23.
109. Shammas RL, Movahed A. Sarcoidosis of the heart. Clin Cardiol 1993;16:462-72.
110. Perry A, Vuitch F. Causes of death in patients with sarcoidosis: a morphologic study of 38 autopsies with clinicopathologic correlations. Arch Pathol Lab Med 1995;119:167-72.
111. Hirose Y, Ishida Y, Hayashida K, et al. Myocardial involvement in patients with sarcoidosis: an analysis of 75 patients. Clin Nucl Med 1994;19:522-6.
112. Okayama K, Kurata C, Tawarahara K, Wakabayashi Y, Chida K, Sato A. Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis. Chest 1995;107:330-4.
113. Fuss M, Pepersack T, Gillet C, Karmali R, Corvilain J. Calcium and vitamin D metabolism in granulomatous diseases. Clin Rheumatol 1992;11:28-36.
114. Basile JN, Liel Y, Shary J, Bell NH. Increased calcium intake does not suppress circulating 1,25-dihydroxyvitamin D in normocalcemic patients with sarcoidosis. J Clin Invest 1993;91:1396-8.
115. Consensus conference: activity of sarcoidosis. Eur Respir J 1994;7:624-7.
116. Maná J, Salazar A, Manresa F. Clinical factors predicting persistence of activity in sarcoidosis: a multivariate analysis of 193 cases. Respiration 1994;61:219-25.
117. Takada K, Ina Y, Noda M, Sato T, Yamamoto M, Morishita M. The clinical course and prognosis of patients with severe, moderate or mild sarcoidosis. J Clin Epidemiol 1993;46:359-66.
118. Marcille R, McCarthy M, Barton JW, Merten DF, Spock A. Long-term outcome of pediatric sarcoidosis with emphasis on pulmonary status. Chest 1992;102:1444-9.
119. DeRemee RA. Sarcoidosis. Mayo Clin Proc 1995;70:177-81.
120. Turner-Warwick M, McAllister W, Lawrence R, Britten A, Haslam PL. Corticosteroid treatment in pulmonary sarcoidosis: do serial lavage lymphocyte counts, serum angiotensin converting enzyme measurements, and gallium-67 scans help management? Thorax 1986;41:903-13.
121. Murdoch J, Müller NL. Pulmonary sarcoidosis: changes on follow-up CT examination. AJR Am J Roentgenol 1992;159:473-7.
122. Miller A, Brown LK, Sloane MF, Bhuptani A, Teirstein AS. Cardiorespiratory responses to incremental exercise in sarcoidosis patients with normal spirometry. Chest 1995;107:323-9.
123. Laviolette M, La Forge J, Tennina S, Boulet L-P. Prognostic value of bronchoalveolar lavage lymphocyte count in recently diagnosed pulmonary sarcoidosis. Chest 1991;100:380-4.
124. Bjermer L, Eklund A, Blaschke E. Bronchoalveolar lavage fibronectin in patients with sarcoidosis: correlation to hyaluronan and disease activity. Eur Respir J 1991;4:965-71.
125. Eklund A, Blaschke E. Elevated serum neopterin levels in sarcoidosis. Lung 1986;164:325-32.
126. Gibson GJ, Prescott RJ, Muers MF, et al. British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment. Thorax 1996;51:238-47.
127. Sharma OP. Pulmonary sarcoidosis and corticosteroids. Am Rev Respir Dis 1993;147:1598-600.
128. Selroos O. Treatment of sarcoidosis. Sarcoidosis 1994;11:80-3.
129. du Bois RM. Corticosteroids in sarcoidosis: friend or foe? Eur Respir J 1994;7:1203-9.
130. Hunninghake GW, Gilbert S, Pueringer R, et al. Outcome of the treatment for sarcoidosis. Am J Respir Crit Care Med 1994;149:893-8.
131. Lower EE, Baughman RP. The use of low dose methotrexate in refractory sarcoidosis. Am J Med Sci 1990;299:153-7.
132. Idem. Prolonged use of methotrexate for sarcoidosis. Arch Intern Med 1995;155:846-51.
133. Kaye O, Palazzo E, Grossin M, Bourgeois P, Kahn MF, Malaise MG. Low-dose methotrexate: an effective corticosteroid-sparing agent in the musculoskeletal manifestations of sarcoidosis. Br J Rheumatol 1995;34:642-4.
134. Henderson CA, Ilchyshyn A, Curry AR. Laryngeal and cutaneous sarcoidosis treated with methotrexate. J R Soc Med 1994;87:632-3.
135. Webster GF, Razsi LK, Sanchez M, Shupack JL. Weekly low-dose methotrexate therapy for cutaneous sarcoidosis. J Am Acad Dermatol 1991;24:451-4.
136. Casavilla FA, Gordon R, Wright HI, Gavaler JS, Starzl TE, Van Thiel DH. Clinical course after liver transplantation in patients with sarcoidosis. Ann Intern Med 1993;118:865-6.
137. Oni AA, Hershberger RE, Norman DJ, et al. Recurrence of sarcoidosis in a cardiac allograft: control with augmented corticosteroids. J Heart Lung Transplant 1992;11:367-9.
138. Zic JA, Horowitz DH, Arzubiaga C, King LE Jr. Treatment of cutaneous sarcoidosis with chloroquine: review of the literature. Arch Dermatol 1991;127:1034-40.
139. Adams JS, Diz MM, Sharma OP. Effective reduction in the serum 1,25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia with short-course chloroquine therapy. Ann Intern Med 1989;111:437-8.
140. Milman N, Graudal N, Grode G, Munch E. No effect of high-dose inhaled steroids in pulmonary sarcoidosis: a double-blind, placebo-controlled study. J Intern Med 1994;236:285-90.
141. Alberts C, van der Mark TW, Jansen HM, Dutch Study Group on Pulmonary Sarcoidosis. Inhaled budesonide in pulmonary sarcoidosis: a double-blind, placebo-controlled study. Eur Respir J 1995;8:682-8.
142. Zych D, Pawlicka L, Zielinski J. Inhaled budesonide vs. prednisone in the maintenance treatment of pulmonary sarcoidosis. Sarcoidosis 1993;10:56-61.
143. Fouty BW, Pomeranz M, Thigpen TP, Martin RJ. Dilatation of bronchial stenoses due to sarcoidosis using a flexible fiberoptic bronchoscope. Chest 1994;106:677-80.
144. Ball JB, Delaney JC, Evans CC, Donnelly RJ, Hind CRK. Endoscopic bougie and balloon dilatation of multiple bronchial stenoses: 10 year follow up. Thorax 1991;46:933-5.
145. Johnson BA, Duncan SR, Ohori NP, et al. Recurrence of sarcoidosis in pulmonary allograft recipients. Am Rev Respir Dis 1993;148:1373-7.
146. Kazerooni EA, Jackson C, Cascade PN. Sarcoidosis: recurrence of primary disease in transplanted lungs. Radiology 1994;192:461-4.
147. Martinez FJ, Orens JB, Deeb M, Brunsting LA, Flint A, Lynch JP III. Recurrence of sarcoidosis following bilateral allogeneic lung transplantation. Chest 1994;106:1597-9.
148. Valantine HA, Tazelaar HD, Macoviak J, et al. Cardiac sarcoidosis: response to steroids and transplantation. J Heart Transplant 1987;6:244-50.
149. Paz HL, McCormick DJ, Kutalek SP, Patchefsky A. The automated implantable cardiac defibrillator: prophylaxis in cardiac sarcoidosis. Chest 1994;106:1603-7.
150. Volden G. Successful treatment of chronic skin diseases with clobetasol propionate and a hydrocolloid occlusive dressing. Acta Derm Venereol 1992;72:69-71.
151. Russo G, Millikan LE. Cutaneous sarcoidosis: diagnosis and treatment. Compr Ther 1994;20:418-21.
152. Yamada H, Ide A, Sugiura M, Tajima S. Treatment of cutaneous sarcoidosis with tranilast. J Dermatol 1995;22:149-52.
153. Carlesimo M, Giustini S, Rossi A, Bonaccorsi P, Calvieri S. Treatment of cutaneous and pulmonary sarcoidosis with thalidomide. J Am Acad Dermatol 1995;32:866-9.
154. Silver MR, Messner LV. Sarcoidosis and its ocular manifestations. J Am Optom Assoc 1994;65:321-7.
155. Sharma OP, Sharma AM. Sarcoidosis of the nervous system: a clinical approach. Arch Intern Med 1991;151:1317-21.
156. Stern BJ, Schonfeld SA, Sewell C, Krumholz A, Scott P, Belendiuk G. The treatment of neurosarcoidosis with cyclosporine. Arch Neurol 1992;49:1065-72.
157. Scott TF. Neurosarcoidosis: progress and clinical aspects. Neurology 1993;43:8-12.
158. Luke RA, Stern BJ, Krumholz A, Johns CJ. Neurosarcoidosis: the long-term clinical course. Neurology 1987;37:461-3.
159. Casella FJ, Allon M. The kidney in sarcoidosis. J Am Soc Nephrol 1993;3:1555-62.